WP
Woodline Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.9M | Sell |
58,778
-47,439
| -45% | -$24.9M | 0.16% | 185 |
|
|
2025
Q1 | $67.4M | Buy |
106,217
+2,938
| +3% | +$1.86M | 0.44% | 40 |
|
|
2024
Q4 | $73.6M | Buy |
103,279
+3,862
| +4% | +$2.75M | 0.5% | 35 |
|
|
2024
Q3 | $105M | Sell |
99,417
-82,480
| -45% | -$86.7M | 0.88% | 14 |
|
|
2024
Q2 | $191M | Buy |
181,897
+11,295
| +7% | +$11.9M | 1.82% | 2 |
|
|
2024
Q1 | $164M | Buy |
170,602
+512
| +0.3% | +$493K | 1.51% | 3 |
|
|
2023
Q4 | $149M | Buy |
170,090
+33,518
| +25% | +$29.4M | 1.62% | 3 |
|
|
2023
Q3 | $112M | Buy |
136,572
+88,910
| +187% | +$73.2M | 1.32% | 7 |
|
|
2023
Q2 | $34.2M | Sell |
47,662
-106,659
| -69% | -$76.6M | 0.41% | 61 |
|
|
2023
Q1 | $127M | Sell |
154,321
-5,172
| -3% | -$4.25M | 1.73% | 2 |
|
|
2022
Q4 | $115M | Sell |
159,493
-27,864
| -15% | -$20.1M | 1.54% | 4 |
|
|
2022
Q3 | $129M | Buy |
187,357
+134,565
| +255% | +$92.7M | 1.8% | 3 |
|
|
2022
Q2 | $31.2M | Sell |
52,792
-52,702
| -50% | -$31.2M | 0.48% | 47 |
|
|
2022
Q1 | $73.7M | Buy |
105,494
+15,248
| +17% | +$10.6M | 1.2% | 7 |
|
|
2021
Q4 | $57M | Buy |
90,246
+14,400
| +19% | +$9.09M | 0.82% | 25 |
|
|
2021
Q3 | $45.9M | Sell |
75,846
-2,013
| -3% | -$1.22M | 0.75% | 26 |
|
|
2021
Q2 | $43.5M | Sell |
77,859
-108,040
| -58% | -$60.3M | 0.81% | 27 |
|
|
2021
Q1 | $88M | Buy |
185,899
+165,695
| +820% | +$78.4M | 1.95% | 5 |
|
|
2020
Q4 | $9.76M | Buy |
+20,204
| New | +$9.76M | 0.26% | 117 |
|
|
2020
Q3 | – | Sell |
-30,722
| Closed | -$19.2M | – | 214 |
|
|
2020
Q2 | $19.2M | Buy |
30,722
+3,245
| +12% | +$2.02M | 0.76% | 48 |
|
|
2020
Q1 | $13.4M | Buy |
+27,477
| New | +$13.4M | 0.96% | 33 |
|